Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Z Gerontol Geriatr ; 56(5): 382-387, 2023 Aug.
Article in German | MEDLINE | ID: mdl-37394541

ABSTRACT

The timely integration of palliative medicine is an important component in the treatment of various advanced diseases. While a German S­3-guideline on palliative medicine exists for patients with incurable cancer, a recommendation for non-oncological patients and especially for palliative patients presenting in the emergency department or intensive care unit is missing to date. Based on the present consensus paper, the palliative care aspects of the respective medical disciplines are addressed. The timely integration of palliative care aims to improve quality of life and symptom control in clinical acute and emergency medicine as well as intensive care.


Subject(s)
Emergency Medicine , Quality of Life , Humans , Consensus , Critical Care , Palliative Care
2.
Anaesthesiologie ; 72(8): 590-595, 2023 08.
Article in German | MEDLINE | ID: mdl-37394611

ABSTRACT

The timely integration of palliative medicine is an important component in the treatment of various advanced diseases. While a German S­3-guideline on palliative medicine exists for patients with incurable cancer, a recommendation for non-oncological patients and especially for palliative patients presenting in the emergency department or intensive care unit is missing to date. Based on the present consensus paper, the palliative care aspects of the respective medical disciplines are addressed. The timely integration of palliative care aims to improve quality of life and symptom control in clinical acute and emergency medicine as well as intensive care.


Subject(s)
Emergency Medicine , Quality of Life , Humans , Consensus , Critical Care , Intensive Care Units
3.
Pneumologie ; 77(8): 544-549, 2023 Aug.
Article in German | MEDLINE | ID: mdl-37399837

ABSTRACT

The timely integration of palliative medicine is an important component in the treatment of various advanced diseases. While a German S-3-guideline on palliative medicine exists for patients with incurable cancer, a recommendation for non-oncological patients and especially for palliative patients being treated in the emergency department or intensive care unit is missing to date. Based on the present consensus paper, the palliative care aspects of the respective medical disciplines are addressed. The timely integration of palliative care aims to improve quality of life and symptom control in clinical acute and emergency medicine as well as intensive care.


Subject(s)
Emergency Medicine , Quality of Life , Humans , Consensus , Critical Care , Palliative Care
4.
Med Klin Intensivmed Notfmed ; 118(Suppl 1): 14-38, 2023 Dec.
Article in German | MEDLINE | ID: mdl-37285027

ABSTRACT

The integration of palliative medicine is an important component in the treatment of various advanced diseases. While a German S3 guideline on palliative medicine exists for patients with incurable cancer, a recommendation for non-oncological patients and especially for palliative patients presenting in the emergency department or intensive care unit is missing to date. Based on the present consensus paper, the palliative care aspects of the respective medical disciplines are addressed. The timely integration of palliative care aims to improve quality of life and symptom control in clinical acute and emergency medicine as well as intensive care.


Subject(s)
Emergency Medicine , Quality of Life , Humans , Consensus , Critical Care , Intensive Care Units , Palliative Care
5.
Hypertens Res ; 44(12): 1568-1577, 2021 12.
Article in English | MEDLINE | ID: mdl-34548653

ABSTRACT

Therapy-resistant hypertension is a serious medical problem, causing end-organ damage, stroke, and heart failure if untreated. Since the standard of care fails in resistant hypertension patients, there is still a substantial unmet medical need for effective therapies. Active stimulation of soluble guanylyl cyclase via novel soluble guanylyl cyclase stimulators might provide an effective treatment option. To test this hypothesis, we established a new experimental dog model and investigated the effects of the soluble guanylyl cyclase-stimulator BAY 41-2272. In beagle dogs, a resistant hypertension phenotype was established by combining unilateral renal wrapping with the occlusion of the renal artery in the contralateral kidney. The most frequently used antihypertensive drugs were administered orally, either alone or in combination, and their acute effect on telemetric measured blood pressure was assessed and compared with that of BAY 41-2272. The chosen disease stimulus led to a moderate and stable increase in blood pressure. Even high doses of standard-of-care antihypertensives only slightly decreased blood pressure. In contrast, the administration of the soluble guanylyl cyclase stimulator BAY 41-2272 as standalone therapy led to a dose-dependent reduction in blood pressure (-14.1 ± 1.8 mmHg). Moreover, BAY 41-2272 could also further decrease blood pressure in addition to a triple combination of standard-of-care antihypertensives (-28.6 ± 13.2 mmHg). BAY 41-2272 was highly efficient as a standalone treatment in resistant hypertension but was also effective in addition to standard-of-care treatment. These data strongly suggest that soluble guanylyl cyclase stimulators might provide an effective pharmacologic therapy for patients with resistant hypertension.


Subject(s)
Hypertension , Pyrazoles/pharmacology , Pyridines/pharmacology , Soluble Guanylyl Cyclase , Animals , Blood Pressure , Dogs , Hypertension/drug therapy , Nitric Oxide , Pyrimidines
SELECTION OF CITATIONS
SEARCH DETAIL
...